Drug · DIN 01919490
CEFIZOX
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since October 19, 2005; first marketed December 31, 1988.
- Drug Identification Number (DIN)
- 01919490
- Company (DIN owner)
- Glaxosmithkline IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous; Intramuscular
- Therapeutic class (ATC)
- Ceftizoxime J01DD07
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CEFTIZOXIME SODIUM | 1 G | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 15, 2001: NOC 2116New Drug Submission (NDS) · Change in manufacturer name
Other DINs named CEFIZOX
- DIN 01919504 · Cancelled Post Market